ReviewJournal of the Endocrine Society2020
SARS-CoV-2 (COVID-19) and the Endocrine System.
Review in Journal of the Endocrine Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy.Journal for immunotherapy of cancer · 2021Pooled it
- Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era.Frontiers in immunology · 2021Pooled it
- Polyuria in COVID-19 Patients Undergoing Extracorporeal Membrane Oxygenation.Journal of clinical medicine · 2024Article
- Evaluation of the hypothalamo-pituitary-adrenal axis during the post-COVID-19 period in patients treated with steroids during the illness.Archives of endocrinology and metabolism · 2023Article
- Interactions between COVID-19 infection and diabetes.Frontiers in endocrinology · 2023Review
- Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry.Journal of virology · 2022Article
- COVID-19 and Long-Term Outcomes: Lessons from Other Critical Care Illnesses and Potential Mechanisms.American journal of respiratory cell and molecular biology · 2022Article
- Surge in testicular torsion in pediatric patients during the COVID-19 pandemic.Journal of pediatric surgery · 2022Observational
- Post-mortem histopathology of pituitary and adrenals of COVID-19 patients.Legal medicine (Tokyo, Japan) · 2022Article
- New-Onset and Persistent Insulin-Dependent Diabetes in Patients With COVID-19: A Peruvian Experience.Cureus · 2022Article
- Pheochromocytoma triggered by coronavirus disease 2019: a case report.Journal of medical case reports · 2022Article
- [Hypophysitis and reversible hypopituitarism developed after COVID-19 infection - a clinical case report].Problemy endokrinologii · 2022Article
- Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome-Prevalence and associated factors: A Mediterranean case series.Clinical endocrinology · 2022Article
- Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review.Microorganisms · 2022Review
- Post-COVID-19 menstrual abnormalities and infertility: Repercussions of the pandemic.Journal of education and health promotion · 2022Review
- Growth hormone level in COVID-19 patients.Northern clinics of Istanbul · 2022Article
- Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours.Biomedicines · 2021Article
- COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain's thyroiditis.BMJ case reports · 2021Article
- Early and late endocrine complications of COVID-19.Endocrine connections · 2021Review
- Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection.The Journal of clinical endocrinology and metabolism · 2021Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As SARS-CoV-2 (COVID-19) overtakes the world, causing moderate to severe disease in about 15% of infected patients, COVID-19 is also found to have widespread effects throughout the body with a myriad of clinical manifestations including the endocrine system. This manuscript reviews what is known about the impact of COVID-19 on the pathophysiology and management of diabetes (both outpatient and inpatient) as well as pituitary, adrenal, thyroid, bone, and gonadal function. Findings in this area are evolving, and long-term effects of infection remain an active area of further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.